Scholar

John De Vos

H-index: 70
Biology 37%
Environmental science 10%

Reposted by John De Vos

by Eric J. TopolReposted by John De Vos

by Eric J. TopolReposted by John De Vos

jdevos.bsky.social
Novo Withdraws from $598M Heartseed Partnership; Pursues Short-Term Profit Over #iPSC Potential.

buff.ly/fJOpc4R
jdevos.bsky.social
Danièle Noël from the IRMB Institute (Montpellier) share her works on MSC-derived EVs. Great work!
#ITD2025
jdevos.bsky.social
Sjoukje van der Stegen, from the Chan Zuckerberg Biohub New York share her works on iPS-derived #CARTCells.
#ITD2025
jdevos.bsky.social
Happy to participate and proud to contribute to this fifth Innovative Therapies Days (ITD) 2025 conference in Besançon.
Great science, biotech and networking!
#ITD2025
jdevos.bsky.social
Aponévrose musculaire. Oui, certaines structures ne sont nécessairement citées dans le cours.

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

alexis-verger.cpesr.fr
Will chemists be happy tomorrow 🍾, or will they say, “Here we go again with biology” 😡 for the Nobel Prize in Chemistry? #chemnobel 😬

Reposted by John De Vos

jdevos.bsky.social
Immunology is back in the spotlight! The 2025 Nobel Prize in Physiology or Medicine has been awarded to research on TReg lymphocytes.

www.nobelprize.org/prizes/medic...

#NobelPrize

Reposted by John De Vos

itaiyanai.bsky.social
Congratulations to Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi for this year's Nobel Prize in Physiology or Medicine. It also demonstrates the fairness of the prize, as Mary Brunkow is a Senior Program Manager (not a professor) at the @isbscience.org
hood.isbscience.org/people/mary-...

Reposted by John De Vos

albertvilella.bsky.social
@rohanpaul.bsky.social , not active on #Bluesky, on the comparisons between the AI revolution and the dot-com bubble of the 2000s.

by Naftali KaminskiReposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

References

Fields & subjects

Updated 1m